
ValiRx - Signs Letter of Intent to Sub-License VAL201
VAL Tue, 02 Nov 2021, 05:00pm GMT
Dr Suzy Dilly, CEO of ValiRx discusses the recently signed letter of intent with TheoremRx Inc to sub-license ValiRx's legacy asset VAL201.

Suzanne Dilly
Chief Executive Officer
Suzanne Dilly, Chief Executive Officer
Thu, 30 Jun 2022, 11:00am BST
Management Team, ValiRx PLC
Wed, 6 Apr 2022, 5:00pm BST
Suzanne Dilly, Chief Executive Officer
Wed, 23 Mar 2022, 12:56pm GMT
Suzanne Dilly, Chief Executive Officer
Wed, 5 Jan 2022, 12:00pm GMT
Suzanne Dilly, Chief Executive Officer
Mon, 20 Dec 2021, 12:20pm GMT
Suzanne Dilly, Chief Executive Officer
Fri, 26 Nov 2021, 4:48pm GMT
Suzanne Dilly, Chief Executive Officer
Tue, 2 Nov 2021, 5:00pm GMT
Suzanne Dilly, Chief Executive Officer
Fri, 28 May 2021, 12:30pm BST
Suzanne Dilly, Chief Executive Officer
Mon, 15 Feb 2021, 12:00pm GMT
Dr Suzanne Dilly and Dr Kevin Cox
Tue, 8 Dec 2020, 2:00pm GMT
Suzanne Dilly, Chief Executive Officer
Mon, 30 Nov 2020, 3:30pm GMT
Suzanne Dilly, Chief Executive Officer
Wed, 30 Sep 2020, 9:00am BST
Suzanne Dilly, Chief Executive Officer
Wed, 8 Jul 2020, 3:15pm BST
Dr George Morris, Chief Operating Officer
Wed, 11 Sep 2019, 4:10pm BST
Victoria D'Aquino, Research and Development Officer
Thu, 4 Jul 2019, 9:00am BST
Dr George Morris, Chief Operating Officer
Thu, 20 Jun 2019, 12:20pm BST
Dr George Morris, Chief Operating Officer
Thu, 2 May 2019, 1:16pm BST
Suzanne Dilly, CEO, ValiSeek Limited
Tue, 18 Dec 2018, 12:00pm GMT